The following is a summary of "Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies," ...

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, established a partnership with Oncoclínicas&Co, through OC Medicina de ...

The costs of genomic sequencing have fallen very rapidly for the past decade and will continue to do so. As it becomes less ...

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...

Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...

The Genomics in Cancer Care Market has witnessed substantial growth over the years, fueled by rapid advancements in precision medicine, next-generation sequencing (NGS), and personalized cancer ...

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...

Integrating aggressive variant prostate cancer–associated tumor suppressor genes (AVPC-TSG) status to refine prognosis and predict androgen-receptor pathway inhibitors (ARPI) response in metastatic ...

Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis with improved efficiency and ease of use.